Stock listing

Frankfurt:TGNA Transgene SA Aktie

German listing (Frankfurt) of Transgene SA · home listing Euronext:TNG

Follow Transgene SA into a list and get an email when it puts out news.

Share price · FWB:TGNA

€0.694 EUR -0.012 (-1.7%)

Close on Nov 16, 2026

Past year -43.2% · daily closes, Nov 17, 2025 – Nov 6, 2026, adjusted for splits
Day range
€0.694 – €0.694 EURNov 16, 2026
Market cap
€193.1M EURAt the close on Nov 16, 2026 · price × 278.3M shares outstanding
52-week range
€0.595 – €1.314 EURLowest and highest trades, Nov 17, 2025 – Nov 16, 2026
Traded on an average day
€7,888 EURMedian day 0 shares · 45 days with no trades · last 3 months, Aug 17, 2026 – Nov 6, 2026
Transgene SA logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Euronext:TNG · Home€0.715 EUR-0.006 (-0.8%)45,941€0.720€0.720€0.707€0.721Close on Nov 16, 2026
LSE:0OCQ€0.716 EUR-0.004 (-0.6%)99€0.722€0.722€0.716€0.720Close on Nov 16, 2026
OTC:TRGNF$0.745 USD0.000 (0.0%)—$0.745$0.745$0.745$0.745Close on Nov 6, 2026
Frankfurt:TGNA€0.694 EUR-0.012 (-1.7%)—€0.694€0.694€0.694€0.706Close on Nov 16, 2026

Daily closes

Last 3 months, Aug 17, 2026 – Nov 6, 2026 · FWB:TGNA · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€0.718-0.011-1.5%€0.718€0.718€0.7180
€0.729-0.008-1.1%€0.729€0.729€0.7290
€0.737-0.082-10.0%€0.737€0.737€0.73799,776
€0.819+0.123+17.7%€0.722€0.819€0.7180
€0.696+0.003+0.4%€0.696€0.696€0.6960
€0.693-0.021-2.9%€0.693€0.693€0.693656
€0.714+0.061+9.3%€0.714€0.714€0.71439,748
€0.653-0.001-0.2%€0.653€0.653€0.65356,930
€0.654-0.003-0.5%€0.654€0.654€0.6540
€0.657+0.004+0.6%€0.657€0.657€0.6576,680
€0.653+0.002+0.3%€0.653€0.653€0.653700
€0.651-0.002-0.3%€0.651€0.651€0.6510
€0.653-0.001-0.2%€0.653€0.653€0.6530
€0.654-0.006-0.9%€0.654€0.654€0.6540
€0.660+0.006+0.9%€0.660€0.660€0.6600
€0.654-0.017-2.5%€0.654€0.654€0.6540
€0.671+0.006+0.9%€0.671€0.671€0.6710
€0.665-0.008-1.2%€0.665€0.665€0.6650
€0.6730.0000.0%€0.673€0.673€0.6730
€0.673+0.012+1.8%€0.673€0.673€0.6730
€0.661-0.022-3.2%€0.661€0.661€0.66111,272
€0.683-0.017-2.4%€0.683€0.683€0.68334,400
€0.700-0.002-0.3%€0.700€0.700€0.7000
€0.702+0.026+3.8%€0.702€0.702€0.7020
€0.676-0.015-2.2%€0.676€0.676€0.6760
€0.691-0.006-0.9%€0.691€0.691€0.6911,700
€0.697-0.004-0.6%€0.697€0.697€0.6970
€0.701-0.005-0.7%€0.701€0.701€0.7010
€0.706-0.032-4.3%€0.706€0.706€0.7060
€0.738-0.047-6.0%€0.738€0.738€0.7380
€0.785-0.039-4.7%€0.785€0.785€0.78567,608
€0.824-0.011-1.3%€0.824€0.824€0.8240
€0.835+0.006+0.7%€0.835€0.835€0.8350
€0.829-0.005-0.6%€0.829€0.829€0.8290
€0.8340.0000.0%€0.834€0.834€0.8340
€0.834-0.006-0.7%€0.834€0.834€0.83437,994
€0.840+0.005+0.6%€0.840€0.840€0.8400
€0.835-0.016-1.9%€0.835€0.835€0.8350
€0.851+0.002+0.2%€0.851€0.851€0.8510
€0.849-0.006-0.7%€0.849€0.849€0.8490
€0.855+0.001+0.1%€0.855€0.855€0.85532,200
€0.854-0.003-0.4%€0.854€0.854€0.8540
€0.857-0.030-3.4%€0.857€0.857€0.8570
€0.887+0.055+6.6%€0.887€0.887€0.8870
€0.832-0.031-3.6%€0.832€0.832€0.8320
€0.863+0.085+10.9%€0.863€0.863€0.863126,540
€0.778+0.020+2.6%€0.778€0.778€0.7780
€0.758-0.017-2.2%€0.758€0.758€0.7580
€0.775-0.001-0.1%€0.775€0.775€0.7750
€0.776-0.004-0.5%€0.776€0.776€0.7760
€0.780-0.008-1.0%€0.780€0.780€0.78096,402
€0.788+0.002+0.3%€0.788€0.788€0.7880
€0.786+0.098+14.2%€0.786€0.786€0.7860
€0.688-0.069-9.1%€0.688€0.688€0.6880
€0.757+0.023+3.1%€0.757€0.757€0.7570
€0.734-0.061-7.7%€0.734€0.734€0.734120
€0.795+0.090+12.8%€0.795€0.795€0.7950
€0.705+0.003+0.4%€0.705€0.705€0.7050
€0.702+0.093+15.3%€0.702€0.702€0.7020
€0.609-0.003-0.5%€0.609€0.609€0.6090
Ticker
Frankfurt:TGNA
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

What changed lately

Calls

Replays

  • Transgene (Euronext:TNG) Q4 2025 Earnings Call

    Tue, Mar 24, 2026 · 1:00 PM ET

    Watch Transcript
  • Transgene (Euronext:TNG) Q2 2025 Earnings Call

    Tue, Sep 16, 2025 · 12:00 PM ET

    Watch Transcript

Latest news

All Transgene SA news

Financings

  • Private placement of new ordinary shares

    Nov 25, 2025 · US$121.48M

    Update: about €105M · Van Lanschot Kempen NV +1

    Dealers: Van Lanschot Kempen NV (lead), Swiss Life Banque Privée (co-lead)

    Buyers: TSGH (irrevocably committed to subscribe for at least €70 million); Dassault Group (SITAM Belgium) (with another existing shareholder, intends to participate for €10 million)

    Use of proceeds: Accelerate the myvac individualized cancer vaccine program, R&D costs, and general and administrative expenses; cash runway to early 2028

    Announced Nov 25, 2025 · Update Nov 25, 2025

Read by 6ix AI from the company's releases

Decks

Transgene SA on 6ix

Sector
Health care
Industry
Biotechnology
News releases
36 in the last 12 months · 49 in all · newest Nov 9, 2026 · oldest 2025
Calls
2 calls with a replay · 2 with a transcript · latest Mar 24, 2026
Decks
66 decks · latest Sep 24, 2026

Where Transgene SA is listed

ListingExchangeCountryCurrency
Euronext:TNG · Home listingEuronextFranceEUR
gettex:TGNAgettexGermanyEUR
LSE:0OCQLSEUnited KingdomEUR
LS Exchange:913048LS ExchangeGermanyEUR
Lang & Schwarz:913048Lang & SchwarzGermanyEUR
Munich:TGNAMunichGermanyEUR
OTC:TRGNFOTCUnited StatesUSD
Frankfurt:TGNA · This pageFrankfurtGermanyEUR
Stuttgart:TGNAStuttgartGermanyEUR
Aquis:TNGPAquisUnited KingdomEUR
Aquis:TNGPAquisUnited KingdomEUR
Dusseldorf:TGNADusseldorfGermanyEUR
Hamburg:TGNAHamburgGermanyEUR
Turquoise:TNGPTurquoiseUnited KingdomEUR

Log in to ask 6ix AI your own questions about Transgene SA.